Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride
Authors:
- Hubertus I.J. HarinckHHHubertus I.J. Harinck
- Olav L.M. BijvoetOBOlav L.M. Bijvoet
- Andrés.T. PlantinghAPAndrés.T. Plantingh
- Jean-Jacques BodyJBJean-Jacques Body
- Jan Willem F. ElteJEJan Willem F. Elte
- Harm P. SleeboomHSHarm P. Sleeboom
- Johan WildiersJWJohan Wildiers
- Jan P. NeijtJNJan P. Neijt
- 1 June 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 82 (6) , 1133-1142
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- COMPARISON OF AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE, MITHRAMYCIN, AND CORTICOSTEROIDSICALCITONIN IN TREATMENT OF CANCER-ASSOCIATED HYPERCALCAEMIAThe Lancet, 1985
- Treatment of malignant hypercalcaemia with clodronateBritish Journal of Cancer, 1985
- COMPARISON OF INTRAVENOUS (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE AND VOLUME REPLETION IN TUMOUR-INDUCED HYPERCALCAEMIAThe Lancet, 1983
- The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myelomaBritish Journal of Haematology, 1983
- Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: Observations on regulation of serum calciumCalcified Tissue International, 1982
- Comparison of two parenteral diphosphonates in hypercalcemia of malignancyThe American Journal of Medicine, 1982
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.Journal of Clinical Investigation, 1980
- DiphosphonatesCalcified Tissue International, 1979
- INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- Hypercalcemic NephropathyArchives of internal medicine (1960), 1978